Literature DB >> 1815456

Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs.

W F Blum1.   

Abstract

To test the hypothesis that growth hormone (GH) insensitivity is responsible, amongst other mechanisms, for impaired growth in uraemic children, insulin-like growth factor I (IGF-I), IGF-II, IGF binding protein-1 (IGFBP-1), IGFBP-2 and IGFBP-3 were measured by radioimmunoassay in normal control children, in patients with end-stage renal failure (n = 51) and in patients with preterminal chronic renal failure (n = 11) and the production rate of IGF was calculated. A unique pattern of normal IGF-I and IGF-II levels and markedly increased levels of all three IGFBPs was present in uraemia. Measurement of free IGF-II binding capacity, and affinity cross-linking experiments showed that the excess immunoreactive IGFBP was able to bind IGFs. To explain the excess of unoccupied IGF binding sites in uraemia, a mathematical model was developed which describes the production of IGFs and their interaction with IGFBP. Calculations of IGF secretion rates suggested that production of IGF is two orders of magnitude lower in uraemic children than in control children, despite normal GH secretion. It is concluded that in uraemia there is a relative GH insensitivity with respect to IGF production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815456     DOI: 10.1111/j.1651-2227.1991.tb12039.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  9 in total

1.  Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

Authors:  Tetyana L Vasylyeva; Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-03-23       Impact factor: 2.372

2.  Acromegaly and end-stage renal disease: a diagnostic challenge.

Authors:  K Müssig; B Gallwitz; M B Ranke; M Horger; H U Häring; H J Quabbe
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

3.  Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers.

Authors:  N Mizuno; Y Kato; M Iwamoto; A Urae; T Amamoto; T Niwa; Y Sugiyama
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

Review 4.  Growth hormone/insulin-like growth factor system in children with chronic renal failure.

Authors:  Burkhard Tönshoff; Daniela Kiepe; Sonia Ciarmatori
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

Review 5.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Authors:  Ralph Rabkin; Di Fei Sun; Yu Chen; Jane Tan; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

Review 6.  The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.

Authors:  Robert H Mak; Wai W Cheung; Charles T Roberts
Journal:  Growth Horm IGF Res       Date:  2007-09-07       Impact factor: 2.372

7.  Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.

Authors:  B Tönshoff; W F Blum; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

8.  Association between insulin growth factor-1, bone mineral density, and frailty phenotype in children with chronic kidney disease.

Authors:  Vasiliki Karava; John Dotis; Athanasios Christoforidis; Vassilios Liakopoulos; Antonia Kondou; Georgios Tsigaras; Konstantina Tsioni; Konstantinos Kollios; Nikoleta Printza
Journal:  Pediatr Nephrol       Date:  2021-02-17       Impact factor: 3.714

Review 9.  The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.

Authors:  Youngman Oh
Journal:  Kidney Res Clin Pract       Date:  2012-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.